CS logo
small CS logo
Grand Strand Urology

Myrtle Beach, South Carolina, United States

About Grand Strand Urology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Ferring Pharmaceuticals
4
Dendreon
3
Total Rows: 7

Clinical Trials at Grand Strand Urology


During the past decade, Grand Strand Urology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis
2002-04-01
2004-01-01
Completed
261
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
2002-11-01
2004-11-01
Completed
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
2003-03-01
2004-07-01
Completed
164
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
2003-07-01
2009-01-01
Completed
512
A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
2005-01-01
2006-11-01
Completed
460
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
2006-02-01
2007-10-01
Completed
620
Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ
2007-03-01
2009-10-01
Completed
46
Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
2007-05-01
2008-08-01
Completed
133

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Grand Strand Urology" #1 sponsor was "Ferring Pharmaceuticals" with 4 trials, followed by "Dendreon" with 3 trials sponsored, "Abbott" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Grand Strand Urology" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFerring Pharmaceuticals: 4Ferring Pharmaceuticals: 4Dendreon: 3Dendreon: 3Abbott: 1Abbott: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1Pfizer: 1Pfizer: 1Sesen Bio, Inc.: 1Sesen Bio, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAstellas Pharma Inc: 1Astellas Pharma Inc: 1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1

Clinical Trials Conditions at Grand Strand Urology


According to Clinical.Site data, the most researched conditions in "Grand Strand Urology" are "Prostate Cancer" (8 trials), "Bladder Cancer" (1 trials), "Bladder Neoplasms" (1 trials), "Bladder Tumors" (1 trials) and "Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Grand Strand Urology" in a lesser frequency.

Clinical Trials Intervention Types at Grand Strand Urology


Most popular intervention types in "Grand Strand Urology" are "Drug" (10 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Degarelix" (4 trials), "APC-Placebo" (1 trials), "APC8015F" (1 trials), "Enzalutamide" (1 trials) and "Goserelin acetate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Grand Strand Urology


The vast majority of trials in "Grand Strand Urology" are 11 trials for "Male" genders and 1 trials for "All" genders.

Clinical Trials Status at Grand Strand Urology


Currently, there are NaN active trials in "Grand Strand Urology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Grand Strand Urology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Grand Strand Urology, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 3: 4Phase 3: 4Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12